Home
overview

SMi Group’s 22nd annual European Pharmaceutical Market Access, Pricing and Reimbursement conference returns to London from 10-11 October 2016. The conference is one of the most established in the world, focusing on the changes in pricing and reimbursement and market access.

As pharmaceutical global spending is predicted to increase by 29-32% by 2020*, the need for access to cheaper alternative medicines and technology is essential. The use of generics is on the rise and it's expected that by 2020, 88%* of total medicine use will be attributed to generics, over the counter, and non-original branded products.

Source: http://bit.ly/1jb3s88

This year's agenda will have a strong focus on the future of pricing and reimbursement. Other key topics include:

  • Updates on AMNOG and its implication on pricing and reimbursement
  • How biosimilars are affecting your pricing strategy
  • Capture on emerging markets’ regulatory framework to adapt your market access and P&R models
  • Orphan drugs using recent examples to highlight the impact on pricing
  • Cancer drug funding and budget cuts in the UK
  • Innovative solutions beyond the pill
  • Japanese and Turkish regional updates

Attend this conference to:  

  • Learn about new strategies, their strengths, weaknesses and future implications
  • Gain an insight into new pricing strategies in oncology
  • Hear about regional updates and understand how we can learn from these
  • Recognise current trends in HTA: Harmonization of HTA
  • Understand how to use pricing data to maximize profit
  • Consider how biosimilars affect pricing and reimbursement

 

CEO, Directors, Associate Directors, Senior Managers, Managers, Presidents, Vice-Presidents, Senior Consultants, Consultants, Professors in the following fields:

  • Pricing
  • Market Access
  • Health Economics
  • Regulatory
  • HEOR
  • Business Development
  • Marketing
  • Commercial Pricing
  • Medical Affairs
  • Government Affairs
  • Strategic Development

Agency for Medicinal Products and Medical Devices of the Republic of Slovenia; Apex Healthcare Consulting Limited; Association of the British Pharmaceutical Industry (ABPI); Astellas Pharma Europe Ltd; Bristol Myers Squibb; Da Volterra; DOLON LTD; EIMC Pharmaceuticals; Ethical Medicines Industry Group; EUCOPE; Field Fisher Waterhouse; German Pharmaceutical Industry Association; GSK; GSK Biologicals; Hospira UK; Imperial College London; IMS Health; IMS Health UK; Ipsen; Justpharmareports; KOWA; MArS Market Access & Pricing Strategy UG; Meteos Ltd; MSD; MSD Ireland; Myeloma UK; NHS Commercial Solutions; Northumbria NHS Foundation Trust; Open Access; Orion Pharma; Pharmavision; ProQR Therapeutics; Quintiles; Quintiles (UK) Ltd; Sandoz Ag; Sanofi-Synthelabo; The National Pharmaceutical Association Ltd; Thomson Reuters; University of Ferrara;

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Bertram Haussler

Bertram Haussler, Chairman of the Board of Management, IGES Institut

9:10 OPENING ADDRESS: Current challenges in European market access, pricing and reimbursement

Alexander Natz

Alexander Natz, Director, EUCOPE
View Bio

  • A better understanding of pricing issues: Euripid Database
  • EUnetHTA
  • Differential pricing vs international reference pricing
  • 9:50 New Cancer Drug Fund (CDF) UK 2016: What have we learned from the transition period?

    Smita Sealey

    Smita Sealey, UK Engagement Manager, Market Access, IMS Health

  • Is the new CDF working as well as expected?
  • How has this new process increased market access?
  • What to expect next
  • 10:30 Morning Coffee

    11:00 AMNOG: Strengths, challenges and where next?

    Bertram Haussler

    Bertram Haussler, Chairman of the Board of Management, IGES Institut

  • Strengths and challenges of AMNOG
  • How well is AMNOG working for orphan drugs
  • Potential healthcare reform steps
  • 11:40 Value based pricing - is it affordable?

    Patrick Mollon

    Patrick Mollon, Former Director Global Health Economics and Outcomes Research; HEOR Director, Novartis; PMHE2020

  • Cost of the product vs. value to the patient
  • What effect would value based pricing have on market access?
  • Is there potential for this strategy?
  • 12:20 Networking Lunch

    13:40 Unlocking the Value of Biosimilars for Payors, Prescribers, Patients & Industry

    Adam Levysohn

    Adam Levysohn, Head of Global Market Access Biosimilars Business Unit, Biogen Idec

  • 10 years on: The biosimilar landscape and continuing challenges to access
  • Learnings from the Infliximab launch
  • Sustaining value in the long-term in the biosimilar space
  • 14:20 Afternoon Tea

    14:50 Japan: 2016 P&R reforms

    Donald Macarthur

    Donald Macarthur, Global Pharmaceutical Business Analyst ,

  • The changes and their implications
  • New cost effectiveness demands
  • Is Japan still a pharmaceutical pricing paradise?
  • 15:30 Chairman’s Closing Remarks and Close of Day One

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Hans-Juergen Seitz

    Hans-Juergen Seitz, Head of Business Development, IGES Institut.

    9:10 OPENING ADDRESS: Biosimilars and their impact on pricing and reimbursement

    Jorge Mestre-Ferrandiz

    Jorge Mestre-Ferrandiz, Director of Consulting, Office of Health Economics

  • The economics of biosimilars
  • How should we price biosimilars?
  • What can be done by payers to ensure long term savings?
  • 9:50 A Nordic update - market access outlook

    Rasmus Jensen

    Rasmus Jensen, Senior Director, Market Access , Camurus AB

  • The transition to the new system - how well is this working?
  • What are the challenges?
  • How is this affecting market access?
  • 10:30 Morning Coffee

    11:00 The UK pricing and reimbursement landscape

    David Watson

    David Watson, Director of Pricing and PPRS, Association of the British Pharmaceutical Industry (ABPI)
    View Bio

  • Accelerated Access Review (AAR) - an update
  • Current pricing strategies and market access arrangements
  • The future of UK pricing
  • 11:40 East meets West: The Turkish story on market access

  • A fast-growing, high-potential emerging market
  • Access strategies including named-patient use
  • 'Alternative reimbursement model' pilots
  • Donald Macarthur

    Donald Macarthur, Adviser, Proceutica

    12:20 Networking Lunch

    13:20 Current trends in Health Technology Assessment (HTA) and value-related measures

    Simone Breitkopf

    Simone Breitkopf, Head HEOR, Governmental and Public Affairs, Alcon

  • Synergy between payers and European HTA bodies
  • Current requirements for harmonisation of HTA and challenges associated with it
  • Early dialogue for medical devices
  • 14:00 Question & Answer Session

  • Quick summary of the day’s presentations, what were the highlights and what will you be taking away from the conference?
  • Reflecting on developments in innovative solutions for improving quality of care
  • How to save healthcare budgets while improving outcomes?
  • Value based pricing models
  • Managed entry agreements
     
     
     
  • Simone Breitkopf

    Simone Breitkopf, Head HEOR, Governmental and Public Affairs, Alcon

    Panos Kefalas

    Panos Kefalas, Head of Health Economics and Market Access, Cell and Gene Therapy Catapult
    View Bio

    Hans-Juergen Seitz

    Hans-Juergen Seitz, Head of Business Development, IGES Institut.

    14:40 Gene and cell therapies - focusing on expensive and process-intensive therapies

    Panos Kefalas

    Panos Kefalas, Head of Health Economics and Market Access, Cell and Gene Therapy Catapult
    View Bio

  • What is different about reimbursement strategies for gene and cell therapies?
  • Challenges associated with the reimbursement and adoption of these therapies
  • Looking to the future - how to overcome these challenges
  • 15:30 Chairman’s Closing Remarks and Close of Day Two

    +

    FEATURED SPEAKERS

    Alexander Natz

    Alexander Natz

    Director, EUCOPE
    David Watson

    David Watson

    Director of Pricing and PPRS, Association of the British Pharmaceutical Industry (ABPI)
    Panos Kefalas

    Panos Kefalas

    Head of Health Economics and Market Access, Cell and Gene Therapy Catapult

    Adam Levysohn

    Head of Global Market Access Biosimilars Business Unit, Biogen Idec
    Adam Levysohn

    Adam joined the Biogen biosimilars team in June 2015. He brings 13 years of market access experience, primarily from his time with Novo Nordisk in global, regional and affiliate roles including head of global market access and market access Europe. Prior to Novo Nordisk, Adam was responsible for Ilaris (canakinumab) access at Novartis where he worked closely with affiliates to understand contracting opportunities. In his last role he was the head of global market access for the CardioMetabolic franchise at Takeda Pharmaceuticals.

    Alexander Natz

    Director, EUCOPE
    Alexander Natz

    Since 2009, Alexander Natz is Secretary General of the European Confederation of Pharmaceutical Entrepreneurs (www.eucope.org) in Brussels and works as lawyer in his own law firm in Düsseldorf (www.natz-law.com). From 2008 to 2013, he was Head of the Brussels Office of Bundesverband der Pharmazeutischen Industrie e.V. (BPI). Before, he has been a lawyer with Sträter Law Firm in Germany with a special focus on discount agreements and licensing of pharmaceuticals. Dr. Natz also was working in the field of competition law with the European Commission and the pharmaceutical industry. As research assistant at Duke University (USA) he has dealt with international pharmaceutical law. His doctorate was supervised by former judge at the European Court of Justice, Prof. Dr. Dr. Ulrich Everling.

    Bertram Haussler

    Chairman of the Board of Management, IGES Institut
    Bertram Haussler

    Bertram Häussler is the chairman of the IGES Group, a corporation of research and consulting companies specializing in infrastructure and health care. He is a medical doctor, sociologist, and honorary professor of Economics of the Pharmaceutical Industry at the Technical University (TU) Berlin. His research work focuses mainly on industrial economics, health services research, health economics, benefit assessment in medicine as well as drug development in a national and international context.

    David Watson

    Director of Pricing and PPRS, Association of the British Pharmaceutical Industry (ABPI)
    David Watson

    David joined the ABPI in May 2014 and is responsible for management of the 2014 Pharmaceutical Price Regulation Scheme (PPRS), which includes the majority of branded medicines sold to the NHS. The ABPI is the recognised industry body which negotiates the PPRS with Government on behalf of the pharmaceutical industry in the UK. The current 2014 scheme is in place till the end of 2018 and is different in design to previous schemes. Through the 2014 PPRS industry supports the overall growth in spend in branded medicines and has a number of commitments on access and uptake.

    David has extensive commercial experience spanning marketing, sales management and business intelligence. Prior to joining the ABPI David worked in consulting, where he led projects in the Pharmaceutical sector including channel strategy and global product launch planning. David spent much of his career with Pfizer, where he held a variety of UK and European roles. He led much of the Pfizer planning on new sales channels including the Direct to Pharmacy (DTP) initiative which resulted in Pfizer selling directly to all pharmacies across the UK.
     

    Donald Macarthur

    Global Pharmaceutical Business Analyst ,
    Donald Macarthur

    Donald Macarthur is an independent industry consultant on international pharmaceutical business issues and also acts as part-time adviser to the Turkish market access regulatory/market access consultancy and service provider, Proceutica.

    Specialities include pricing & reimbursement (all Europe, Japan/Korea/Taiwan), orphan drugs (Europe, Asia-Pacific), GP & hospital market access, funding of medicines, risk sharing, generics/biosimilars, wholesale and retail distribution, EU parallel trade/US importation, and homecare. Qualifying as a pharmacist, 16 years industry experience followed employment in hospital and community pharmacy. In 1996, Mr Macarthur founded the world’s first periodical in its field, Pharma Pricing Review. He has also written over 90 major analytical reports.

     

    Donald Macarthur

    Adviser, Proceutica
    Donald Macarthur

    Hans-Juergen Seitz

    Head of Business Development, IGES Institut.
    Hans-Juergen Seitz

    Dr. Hans-Juergen Seitz studied biology and holds a PhD in Microbiol-ogy/Biochemistry. Following positions in Regulatory Affairs and as Medical Man-ager, he holds several marketing and market access-related management posi-tions at Hoffmann-La Roche (headquarter and Germany) including responsibility as VP for “Market Affairs” in the German affiliate (e.g. government affairs, sick-ness funds and physicians association relations, market access, evidence genera-tion and health economics, pricing/reimbursement and market research). Exter-nal management education included courses at IMD (Lausanne, Switzerland), Insead (Fontainebleau, France) and at the London Business School (London, United Kingdom). Following Roche, Hans-Juergen Seitz headed the German Pharmacists Association (ABDA) in Berlin. He joined IGES in 2012 as Director Business Development and additionally supports IGES customers as strategic consultant.

    Jorge Mestre-Ferrandiz

    Director of Consulting, Office of Health Economics
    Jorge Mestre-Ferrandiz

    Panos Kefalas

    Head of Health Economics and Market Access, Cell and Gene Therapy Catapult
    Panos Kefalas

    Panos Kefalas is heading the Health Economics and Market Access function at the Cell and Gene Therapy Catapult which provides health economics, pricing, reimbursement and market access expertise to accelerate and maximize cell and gene therapy uptake across major healthcare markets. He brings over 15 years’ experience in pharmaceutical pricing, reimbursement and health economics gained both from senior roles with major HEOR and market access consultancy firms (IMS Health plc, PriceSpective / ICON plc, United BioSource Corporation / Evidera plc) and from managing NICE guidance development. He obtained a PhD in Molecular Medicine from King’s College London, an MBA from Cranfield University and professional training in Health Economics from the University of Oxford and the Centre for Health Economics in York.

    Patrick Mollon

    Former Director Global Health Economics and Outcomes Research; HEOR Director, Novartis; PMHE2020
    Patrick Mollon

    Rasmus Jensen

    Senior Director, Market Access , Camurus AB
    Rasmus Jensen

    Simone Breitkopf

    Head HEOR, Governmental and Public Affairs, Alcon
    Simone Breitkopf

    Smita Sealey

    UK Engagement Manager, Market Access, IMS Health
    Smita Sealey

    Official Media Partner

    Supporters

    Workshops

    HTA and reimbursement decisions for innovative medicines
    Workshop

    HTA and reimbursement decisions for innovative medicines

    Holiday Inn Kensington Forum
    12th October 2016
    London, United Kingdom

    VENUE

    Holiday Inn Kensington Forum

    97 Cromwell Road , London, United Kingdom

    Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

    The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

    This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

    In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

    So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

    HOTEL BOOKING FORM

    60 Seconds Speaker Interview with Gordon Spencer, Regional Market Access Lead, Shire International

    Download

    A snapshot of confirmed attendees 2016

    Download

    60 Seconds Speaker Interview with Smita Sealey, UK Engagement Manager, Market Access, IMS Health.

    Download

    Media Partners


    HealthEconomics.com

    Official Media Partner
    http://www.healtheconomics.com

    A pioneer in the field, HealthEconomics.Com is the world’s most comprehensive and credible website for resources and jobs in healthcare value and market access. A trusted resource, HealthEconomics.Com contains the hottest news, jobs, policy updates, professional development, and education resources, and offers unparalleled advertising opportunities. As the #1 Google ranked website in health economics, HealthEconomics.Com attracts 11,000 visitors every month and the well-respected Newsletter reaches 20,000 professionals every week. The comprehensive content is carefully selected by a discerning health economist editor, making us the most visited website for healthcare value and market access in the industry, with visitors encompassing all corners of the globe.

    Media Partners


    Pharmaceutical Technology

    Supporters
    http://www.pharmaceutical-technology.com

    Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.


    Labsave

    Supporters
    http://www.labsave.com

    Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/


    Copybook - Pharmaceutical

    Supporters
    http://www.copybook.com/pharmaceutical

    Copybook is a global business network with many pharmaceutical events, exhibitions and seminars. We encourage business-to-business transactions and work tirelessly to gain our customers new business contracts worldwide. You can add events, companies and associations for free. When you are a member, you can add your company to the events listed in order to encourage other visitors to arrange meetings and appointments at those events to facilitate new business contracts. Want to see how we can increase your business network and transactions? SIGN UP FOR FREE today! Copybook – Your Global Business Network


    Mednous

    Supporters
    http://www.MedNous.com

    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


    Absave

    Supporters
    http://www.absave.com

    Absave.com is the leading savings website for Antibodies and Immunological Products. Search our extensive database of Antibodies, Kits, Proteins & Peptides, Reagents, etc. to find the best savings!


    Biotechgate

    Supporters
    http://www.biotechgate.com/gate/v3/companies.php

    Biotechgate is a global, comprehensive, life science database covering the Biotech, Pharma and Medtech industries. There are currently over 38,000 company profiles on the Biotechgate database. Biotechgate is commonly used to find product pipelines, collaboration partners, in/out-licensing opportunities and information about technology platforms, management details, new business leads and financing rounds. In addition, our licensing deals database supports companies in negotiating their licensing agreements.


    PharmaVOICE

    Supporters
    http://www.pharmavoice.com

    PharmaVOICE magazine, and its supporting VIEW publications, provide commentary about the challenges and trends impacting the life-sciences industry, covering a range of issues from molecule through market. PharmaVOICE's more than 41,000 U.S.-based subscribers are also kept abreast of the latest trends through additional media resources, including WebSeminars, Podcasts, Videocasts, and White Papers.


    Pharmavision

    Supporters
    http://www.pharmavision.co.uk

    PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.


    Medical News Today

    Supporters
    http://www.medicalnewstoday.com

    Medical News Today is the largest independent medical and health news site on the web - with over 10,000,000 monthly unique users it is ranked number one for medical news on all major search engines. Medical News Today is used by pharmaceutical, biotech and health organizations, advertising agencies, PR companies and vertical ad networks to deliver targeted campaigns to HCPs, patients and caregivers. To find out how Medical News Today can help you to reach the right audience contact peter@medicalnewstoday.com or visit www.medicalnewstoday.com.


    BioChem Adda

    Supporters
    https://www.biochemadda.com/

    BioChem Adda is a Not-just-for-Profit organization which aims to bring out the most reliable and transparent information about everything related to jobs, careers, education, news, articles, and events from the field of BioSciences and Chemistry!


    Gate2Biotech

    Supporters
    http://www.gate2biotech.com

    Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.


    Inderscience Publishers

    Supporters
    http://www.inderscience.com

    Inderscience is a dynamic, leading, independent journal publisher. The company disseminates the latest research across the broad fields of science, engineering and technology; management, public and business administration; environment, ecological economics and sustainable development; computing, ICT and internet/web services, and related areas. Inderscience offers over 35 years' experience in publishing and has succeeded in building a substantial collection approaching 400 high-quality peer-reviewed international research journals in both online and print formats. We offer a variety of ways to keep up-to-date with the latest published leading-edge research while our online collection represents a fully-searchable digital archive of around 60,000 articles.


    Drug Development Technology

    Supporters
    http://www.drugdevelopment-technology.com

    Drugdevelopment-technology.com covers every aspect of the drug development and research process, from conception to pre-FDA approval. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone - from senior management through to research and QA staff – with in-depth reviews of the latest projects, advance notice of new product releases and analysis of the latest procedural and legislative developments.


    My PharmaPlace

    Supporters
    http://www.mypharmaplace.com/

    My PharmaPlace is the first online exhibition dedicated to the pharmaceutical industry. A user-friendly website, accessible 24/7 focused on scientific developments & industrial applications. My PharmaPlace showcases targeted products and services. An online meeting place for laboratories, contract manufacturers, packaging & process providers.


    Cutting Edge

    Supporters
    http://www.cuttingedgeinfo.com

    Cutting Edge Information provides customized research and benchmarking reports to pharmaceutical, biotechnology and other life science companies. We provide off-the-shelf and customized research for key areas including medical affairs, clinical development, market access, regulatory affairs, marketing management, sales and HCP fair market value.


    Pharmacircle

    Supporters
    http://www.pharmacircle.com

    PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….


    Biosave

    Supporters
    http://www.Biosave.com

    Biosave.com brings together the best Life Science promotions, product releases, featured products, publications, videos and events from 100’s of leading Life Science suppliers. Updated 24 hours a day, Biosave is constantly uploading special promotions and exciting product news that you won’t find anywhere else. Our goal is to provide our users with the most exclusive product information to help reach that all important purchasing decision.


    Conference Service

    Supporters
    https://www.conference-service.com/

    COMS is a web based system for managing delegate registration, payment, paper submission, review and the book of abstracts. It is a comprehensive and powerful, yet easy to use solution for online conference management including event planning and creation of the detailed agenda.


    International Journal of Healthcare Technology and Management

    Supporters
    http://www.inderscience.com/ijhtm

    IJHTM is a series emerging from the International Journal of Technology Management. It provides an international forum and refereed authoritative sources of information in the fields of the economics and management of technology in healthcare.


    International Journal of Healthcare Policy

    Supporters
    http://www.inderscience.com/ijhp

    IJHP serves as a forum for interdisciplinary discussion of leading issues in healthcare law, medicine and health policy. Emphasis is placed on issues such as legislative and regulatory environments, and plans and actions that are undertaken by organisations and agencies to achieve specific healthcare goals within society. This perspective is reflective of the broad range of efforts to advance the public's health.


    Technology Networks

    Supporters
    http://www.technologynetworks.com

    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


    Swiss Biotech Association

    Supporters
    http://www.swissbiotech.org/

    The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.


    EIN News

    Supporters
    http://www.einnews.com

    EIN News is the world leader in industry focused online news monitoring. Thousands of leading companies, institutions and global professionals from business, industry, and government rely on EIN News as an indispensable resource. Our systems continuously scan the web, indexing news from thousands of worldwide sources. The news you need is then organized by advanced software systems managed by a team of professional news editors. Everything we do is focused on streamlining your news searches and research in order to save you time and money.


    pharmaphorum

    Supporters
    http://www.pharmaphorum.com

    pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.Visit www.pharmaphorum.com

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Holiday Inn Kensington Forum

    97 Cromwell Road
    London SW7 4DN
    United Kingdom

    Holiday Inn Kensington Forum

    Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

    The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

    This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

    In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

    So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.